フィラリア症治療の世界市場レポート 2025年

フィラリア症治療の市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は11.7%で、179億1,000万米ドルに成長します。予測期間中の成長は、政府プログラム、ヘルスケアソリューションへの注目の高まり、ヘルスケア施設の改善、経口薬需要の高まり、流行地域におけるフィラリア症の継続的な流行などの要因に起因すると考えられます。この期間の主な動向としては、3剤併用療法の導入、より長時間作用する抗フィラリア薬の開発研究の進行、CRISPRおよび分子生物学の進歩、新しい診断ツールの開発、リンパ浮腫の管理技術の向上などが挙げられます。

象皮病の罹患率の増加は、今後数年間のフィラリア症治療市場の成長を促進すると予想されます。象皮病は寄生虫感染によって引き起こされる重篤な疾患で、典型的には腕や脚の皮膚の著しい腫脹と肥厚をもたらします。象皮病患者の増加は、不衛生、大量薬剤投与（MDA）の欠如、不十分なベクターコントロール、治療へのアクセス制限などの要因によるところが大きいです。フィラリア症治療は、根本的な寄生虫感染を標的とし、炎症を抑え、リンパの損傷を防ぐことで、象皮病の発症リスクを下げ、その深刻な症状を緩和します。例えば、2024年11月、世界保健機関（WHO）は、2023年においても39カ国にわたり6億5,700万人以上がリンパ系フィラリア症の危険にさらされており、感染を食い止めるための予防治療が必要であると報告しました。このように、象皮病の有病率の増加がフィラリア症治療市場の成長に拍車をかけています。

ヘルスケア施設の改善もフィラリア症治療市場の成長に寄与すると予想されます。病院、診療所、診断センターなどのヘルスケア施設は、患者に必要不可欠な医療とサービスを提供しています。これらのヘルスケア施設は、医療インフラへの投資の増加、患者中心のケアへの注力、人口増加、高齢化などの要因によって改善されつつあります。ヘルスケア施設の充実により、高度な診断ツール、効果的な薬剤、熟練した医療専門家へのアクセスが確保されます。これにより、広範なスクリーニング、タイムリーな治療、継続的なケアが促進され、患者の転帰が向上し、フィラリア症の負担が軽減されます。例えば、2023年5月に米国医療協会が発表した米国の病院数は6,129で、前年（6,093）から0.591％増加しました。したがって、ヘルスケア施設の充実がフィラリア症治療市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界フィラリア症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のフィラリア症治療市場：成長率分析
• 世界のフィラリア症治療市場の実績：規模と成長, 2019-2024
• 世界のフィラリア症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界フィラリア症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のフィラリア症治療市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジエチルカルバマジン
• イベルメクチン
• アルベンダゾール
• その他の薬物の種類
• 世界のフィラリア症治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 手術
• その他の治療の種類
• 世界のフィラリア症治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のフィラリア症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• その他のエンドユーザー
• 世界のフィラリア症治療市場ジエチルカルバマジンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単剤療法
• 併用療法
• 世界のフィラリア症治療市場イベルメクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与療法
• 集団医薬品管理局（MDA）
• 世界のフィラリア症治療市場アルベンダゾールの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単独治療
• 他の駆虫薬との併用
• 世界のフィラリア症治療市場、その他の薬剤タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドキシサイクリン療法
• 抗ヒスタミン薬と抗炎症薬

第7章 地域別・国別分析

• 世界のフィラリア症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のフィラリア症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• フィラリア症治療市場：競合情勢
• フィラリア症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Dr. Reddy's Laboratories
• Rakshit Drugs
• AdvaCare Pharma
• Orex Pharma Pvt. Ltd.
• Sms Lifesciences
• Enomark Pharma
• Angle Bio Pharma
• Senores Pharmaceuticals Inc.
• Atom pharma
• Devlife Corporation Private Limited
• Orion Life Science
• Heer Pharma Private Limited
• AMGIS Lifescience Ltd.
• Cerata Pharmaceuticals
• Ben Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• フィラリア症治療市場2029：新たな機会を提供する国
• フィラリア症治療市場2029：新たな機会を提供するセグメント
• フィラリア症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Filariasis treatment involves medical interventions aimed at managing and eliminating infections caused by filarial parasites, which are transmitted through mosquito bites. The goal of treatment is to eradicate the infection, relieve symptoms, and prevent severe complications such as lymphedema (elephantiasis) and blindness.

The main drugs used for filariasis treatment include diethylcarbamazine (DEC), ivermectin, albendazole, and others. Diethylcarbamazine is an antiparasitic medication that targets lymphatic filariasis by eliminating microfilariae and certain adult worms. The treatment options include medication, surgery, and other approaches. These treatments are distributed through various channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and more. They are utilized by a range of end-users, including hospitals, clinics, ambulatory surgical centers, and others.

The filariasis treatment market research report is one of a series of new reports from The Business Research Company that provides filariasis treatment market statistics, including the filariasis treatment industry global market size, regional shares, competitors with the filariasis treatment market share, detailed filariasis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the filariasis treatment industry. This filariasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The filariasis treatment market size has grown rapidly in recent years. It will grow from $10.26 billion in 2024 to $11.50 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth during the historic period can be attributed to factors such as the rising incidence of filariasis cases, increased funding, greater investment in research and development, the impact of climate change, and the growth in international travel.

The filariasis treatment market size is expected to see rapid growth in the next few years. It will grow to $17.91 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth during the forecast period can be attributed to factors such as government programs, an increasing focus on healthcare solutions, improvements in healthcare facilities, rising demand for oral drugs, and the continued prevalence of filariasis in endemic regions. Major trends during this period include the introduction of triple-drug therapy, ongoing research to develop longer-acting anti-filarial medications, advancements in CRISPR and molecular biology, the development of new diagnostic tools, and improved techniques for managing lymphedema.

The increasing incidence of elephantiasis is expected to drive the growth of the filariasis treatment market in the coming years. Elephantiasis is a severe condition caused by parasitic infections, leading to significant swelling and thickening of the skin, typically in the arms and legs. The rise in elephantiasis cases is largely due to factors such as poor sanitation, lack of mass drug administration (MDA), inadequate vector control, and limited access to treatment. Filariasis treatment targets the underlying parasitic infection, reducing inflammation and preventing lymphatic damage, which lowers the risk of developing elephantiasis and helps alleviate its severe symptoms. For example, in November 2024, the World Health Organization reported that more than 657 million people across 39 countries were still at risk of lymphatic filariasis in 2023 and needed preventive treatment to stop the transmission of the disease. Thus, the increasing prevalence of elephantiasis is fueling the growth of the filariasis treatment market.

The improvement of healthcare facilities is also expected to contribute to the growth of the filariasis treatment market. Healthcare facilities, including hospitals, clinics, and diagnostic centers, provide essential medical care and services to patients. These facilities are improving due to factors such as increased investment in healthcare infrastructure, a focus on patient-centered care, population growth, and an aging demographic. Better healthcare facilities ensure access to advanced diagnostic tools, effective medications, and skilled healthcare professionals. This promotes widespread screenings, timely treatments, and continuous care, which enhances patient outcomes and reduces the burden of filariasis. For example, in May 2023, the American Health Care Association reported that the United States had 6,129 hospitals, marking a 0.591% increase from the previous year, when there were 6,093 hospitals. Therefore, the improvement of healthcare facilities is driving growth in the filariasis treatment market.

In May 2024, the German Center for Infection Research (DZIF), a Germany-based research institution focused on infectious diseases, partnered with Eisai Co., Ltd., a Japan-based pharmaceutical company, to develop treatments for river blindness and lymphatic filariasis. This collaboration aims to address the needs of affected populations in Africa and tropical regions. Eisai Co., Ltd. is known for providing filariasis treatments, including diethylcarbamazine (DEC) tablets.

Major players in the filariasis treatment market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Dr. Reddy's Laboratories, Rakshit Drugs, AdvaCare Pharma, Orex Pharma Pvt. Ltd., Sms Lifesciences, Enomark Pharma, Angle Bio Pharma, Senores Pharmaceuticals Inc., Atom pharma, Devlife Corporation Private Limited, Orion Life Science, Heer Pharma Private Limited, AMGIS Lifescience Ltd., Cerata Pharmaceuticals, Ben Pharmaceuticals, Biofield Pharma Pvt. Ltd.

Asia-Pacific was the largest region in the filariasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in filariasis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the filariasis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The filariasis treatment market consists of revenues earned by entities by providing services such as psychosocial and rehabilitation support, symptom management and supportive care, patient education, and community awareness. The market value includes the value of related goods sold by the service provider or included within the service offering. The filariasis treatment market also includes sales of antiparasitic medications, vector control products, compression garments, topical antibiotics, and antiseptics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Filariasis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on filariasis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for filariasis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The filariasis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Diethylcarbamazine; Ivermectin; Albendazole; Other Drug Types
• 2) By Treatment Type: Medication; Surgery; Other Treatment Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Diethylcarbamazine: Monotherapy; Combination Therapy
• 2) By Ivermectin: Single-Dose Therapy; Mass Drug Administration (MDA)
• 3) By Albendazole: Standalone Treatment; Combination With Other Anthelmintics
• 4) By Other Drug Types: Doxycycline Therapy; Antihistamines And Anti-Inflammatory Drugs
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Eisai Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Filariasis Treatment Market Characteristics

3. Filariasis Treatment Market Trends And Strategies

4. Filariasis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Filariasis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Filariasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Filariasis Treatment Market Growth Rate Analysis
• 5.4. Global Filariasis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Filariasis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Filariasis Treatment Total Addressable Market (TAM)

6. Filariasis Treatment Market Segmentation

• 6.1. Global Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diethylcarbamazine
• Ivermectin
• Albendazole
• Other Drug Types
• 6.2. Global Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• Other Treatment Types
• 6.3. Global Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Filariasis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Other End-Users
• 6.5. Global Filariasis Treatment Market, Sub-Segmentation Of Diethylcarbamazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monotherapy
• Combination Therapy
• 6.6. Global Filariasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Therapy
• Mass Drug Administration (MDA)
• 6.7. Global Filariasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standalone Treatment
• Combination With Other Anthelmintics
• 6.8. Global Filariasis Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Doxycycline Therapy
• Antihistamines And Anti-Inflammatory Drugs

7. Filariasis Treatment Market Regional And Country Analysis

• 7.1. Global Filariasis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Filariasis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Filariasis Treatment Market

• 8.1. Asia-Pacific Filariasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Filariasis Treatment Market

• 9.1. China Filariasis Treatment Market Overview
• 9.2. China Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Filariasis Treatment Market

• 10.1. India Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Filariasis Treatment Market

• 11.1. Japan Filariasis Treatment Market Overview
• 11.2. Japan Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Filariasis Treatment Market

• 12.1. Australia Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Filariasis Treatment Market

• 13.1. Indonesia Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Filariasis Treatment Market

• 14.1. South Korea Filariasis Treatment Market Overview
• 14.2. South Korea Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Filariasis Treatment Market

• 15.1. Western Europe Filariasis Treatment Market Overview
• 15.2. Western Europe Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Filariasis Treatment Market

• 16.1. UK Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Filariasis Treatment Market

• 17.1. Germany Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Filariasis Treatment Market

• 18.1. France Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Filariasis Treatment Market

• 19.1. Italy Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Filariasis Treatment Market

• 20.1. Spain Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Filariasis Treatment Market

• 21.1. Eastern Europe Filariasis Treatment Market Overview
• 21.2. Eastern Europe Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Filariasis Treatment Market

• 22.1. Russia Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Filariasis Treatment Market

• 23.1. North America Filariasis Treatment Market Overview
• 23.2. North America Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Filariasis Treatment Market

• 24.1. USA Filariasis Treatment Market Overview
• 24.2. USA Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Filariasis Treatment Market

• 25.1. Canada Filariasis Treatment Market Overview
• 25.2. Canada Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Filariasis Treatment Market

• 26.1. South America Filariasis Treatment Market Overview
• 26.2. South America Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Filariasis Treatment Market

• 27.1. Brazil Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Filariasis Treatment Market

• 28.1. Middle East Filariasis Treatment Market Overview
• 28.2. Middle East Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Filariasis Treatment Market

• 29.1. Africa Filariasis Treatment Market Overview
• 29.2. Africa Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Filariasis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Filariasis Treatment Market Competitive Landscape
• 30.2. Filariasis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Filariasis Treatment Market Other Major And Innovative Companies

• 31.1. Dr. Reddy's Laboratories
• 31.2. Rakshit Drugs
• 31.3. AdvaCare Pharma
• 31.4. Orex Pharma Pvt. Ltd.
• 31.5. Sms Lifesciences
• 31.6. Enomark Pharma
• 31.7. Angle Bio Pharma
• 31.8. Senores Pharmaceuticals Inc.
• 31.9. Atom pharma
• 31.10. Devlife Corporation Private Limited
• 31.11. Orion Life Science
• 31.12. Heer Pharma Private Limited
• 31.13. AMGIS Lifescience Ltd.
• 31.14. Cerata Pharmaceuticals
• 31.15. Ben Pharmaceuticals

32. Global Filariasis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Filariasis Treatment Market

34. Recent Developments In The Filariasis Treatment Market

35. Filariasis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Filariasis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Filariasis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Filariasis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer